Product Information
SAXENDA 18 MG/3 ML PEN is a brand product labeled by Novo Nordisk, priced at $87.1660 per ML under NDC 00169280015. Its NADAC has been published 554 times since Nov 18, 2015.
The High Outlier badge above means this manufacturer's average price in the liraglutide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
6 mg/mL
Manufacturer
Novo NordiskNDC
00169280015
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
LIRAGLUTIDEApproval Type
New Drug (NDA)
FDA Application
NDA206321On Market Since
12/31/2014
Pharmacological Classes
Price Statistics
The NADAC for SAXENDA 18 MG/3 ML PEN has been published 554 times since Nov 18, 2015, and over the history we have for it it has risen 25.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $87.1660 per ML |
|---|---|
| All-time high | $87.1660 (Jun 24, 2026) |
| All-time low | $69.2275 (Nov 18, 2015) |
| 52-week high | $87.1660 |
| 52-week low | $86.9011 |
| Median price | $86.2389 |
| Average price | $81.9393 |
| Largest weekly change | +8.0% (Apr 13, 2016) |
| Weeks tracked | 554 |
| Tracking since | Nov 18, 2015 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 62% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SAXENDA 18 MG/3 ML PEN?
The current National Average Drug Acquisition Cost (NADAC) for SAXENDA 18 MG/3 ML PEN, manufactured by Novo Nordisk, is $87.1660 per ML (NDC 00169280015), effective Jun 24, 2026.
How has the price of SAXENDA 18 MG/3 ML PEN changed over time?
Over the history we have for it, the NADAC for SAXENDA 18 MG/3 ML PEN has risen 25.9%. It has been tracked across 554 weekly CMS publications since Nov 18, 2015.
What are the highest and lowest recorded NADAC prices for SAXENDA 18 MG/3 ML PEN?
Since Nov 18, 2015, the NADAC for SAXENDA 18 MG/3 ML PEN has ranged from a low of $69.2275 (Nov 18, 2015) to a high of $87.1660 (Jun 24, 2026), with a median of $86.2389 per ML.
Are there cheaper alternatives to SAXENDA 18 MG/3 ML PEN?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LIRAGLUTIDE 3-PAK 18 MG/3 ML, is $33.4153 per ML — about 62% below SAXENDA 18 MG/3 ML PEN.
Who manufactures SAXENDA 18 MG/3 ML PEN?
SAXENDA 18 MG/3 ML PEN (NDC 00169280015) is labeled by Novo Nordisk, and CMS classifies it as a brand product.
Related Drugs
Same classification